Asensia Diabetes Care today presented data from 3 studies of its blood glucose monitoring systems, including the 1st presentation of data on its Contour Next One blood glucose monitoring system.
Data from a 43-player study analyzing the usability of its Contour Next One indicated 95.4% of patients were able to sync their meter and app and 95.4% were able to access and interpret the data. A total of 98% reported that blood glucose displays were “understandable” and 89.7% of subjects were able to initiate and use the bolus calculator feature.
“The Contour Diabetes App is designed to collect and display detailed information that may help people with diabetes with their management decisions. This study is the first to assess the system’s ease of use. Tools, such as the Contour Diabetes App, may help more people with diabetes and those who care for them to spot important patterns and trends, with the potential to lead to better health outcomes,” lead investigator Dr. Timothy Bailey of San Diego’s AMCR Institute said in prepared remarks.
A separate study evaluating the accuracy of the Contour Next Link 2.4 wireless meter against a swath of other meters indicated that the meter met accuracy criteria for 2 comparison methods, and was the only meter tested that met more strict accuracy limits for both comparison methods.
“Meter accuracy is particularly important for insulin pump users, as the blood glucose values are directly used to calculate the required insulin dose from the pump and to calibrate the continuous glucose monitoring sensor. High levels of accuracy are important to ensure pump users have safe and appropriate therapy,” lead investigator Dr. Guido Freckmann of the Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft said in a prepared statement.
Another study evaluating the Contour Plus blood glucose monitoring system against 3 other systems reported that the device fulfilled ISO 15197:2013 criteria for both reference methods used in the trial.